Lieberman, Jeffrey A.

Evidence for the Risks and Consequences of Adolescent Cannabis Exposure

Levine, A., Clemenza, K., Rynn, M., & Lieberman, J. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 239

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study

Daumit, G. L., Goff, D. C., Meyer, J. M., Davis, V. G., Nasrallah, H. A., McEvoy, J. P., Rosenheck, R., Davis, S. M., Hsiao, J. K., Stroup, T. S., et al. (2008) · Schizophrenia Research

Schizophrenia research and treatmentCardiac Health and Mental Health

Cited by 223

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery

Poels, E. M. P., Kegeles, L. S., Kantrowitz, J. T., Slifstein, M., Javitt, D. C., Lieberman, J. A., Abi-Dargham, A., & Girgis, R. R. (2014) · Molecular Psychiatry

Schizophrenia research and treatmentAdvanced MRI Techniques and Applications

Cited by 205

Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia

Marx, C. E., Keefe, R. S. E., Buchanan, R. W., Hamer, R. M., Kilts, J. D., Bradford, D. W., Strauss, J. L., Naylor, J. C., Payne, V. M., Lieberman, J. A., et al. (2009) · Neuropsychopharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 193

Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia.

Rosenfeld, A. J., Lieberman, J. A., & Jarskog, L. F. (2011) · Schizophrenia Bulletin

Schizophrenia research and treatmentNeuroendocrine regulation and behavior

Cited by 178

A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia

Buchanan, R. W., Keefe, R. S. E., Lieberman, J. A., Barch, D. M., Csernansky, J. G., Goff, D. C., Gold, J. M., Green, M. F., Jarskog, L. F., Javitt, D. C., et al. (2011) · Biological Psychiatry

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 172

A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia

for the MEM-MD-29 Study Group, Lieberman, J. A., Papadakis, K., Csernansky, J., Litman, R., Volavka, J., Jia, X. D., & Gage, A. (2009) · Neuropsychopharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 162

Relationship between psychostimulant-induced "high" and dopamine transporter occupancy.

Volkow, N. D., Wang, G. J., Fowler, J. S., Gatley, S. J., Ding, Y. S., Logan, J., Dewey, S. L., Hitzemann, R., & Lieberman, J. (1996) · Proceedings of the National Academy of Sciences

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 149

Substance Use in Persons With Schizophrenia: Baseline Prevalence and Correlates From the NIMH CATIE Study

Swartz, M. S., Wagner, H. R., Swanson, J. W., Stroup, T. S., McEvoy, J. P., Canive, J. M., Miller, D. D., Reimherr, F., McGee, M., Khan, A., et al. (2006) · Journal of Nervous & Mental Disease

Schizophrenia research and treatmentSubstance Abuse Treatment and Outcomes

Cited by 146

Metformin for Weight Loss and Metabolic Control in Overweight Outpatients With Schizophrenia and Schizoaffective Disorder

Jarskog, L. F., Hamer, R. M., Catellier, D. J., Stewart, D. D., LaVange, L., Ray, N., Golden, L. H., Lieberman, J. A., Stroup, T. S., & for the METS Investigators (2013) · American Journal of Psychiatry

Schizophrenia research and treatmentPharmacology and Obesity Treatment

Cited by 145

The natural history and pathophysiology of treatment resistant schizophrenia

Sheitman, B. B., & Lieberman, J. A. (1998) · Journal of Psychiatric Research

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 140

Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects

Åberg, K., Adkins, D. E., Bukszár, J., Webb, B. T., Caroff, S. N., Miller, D. D., Sebat, J., Stroup, S., Fanous, A. H., Vladimirov, V. I., et al. (2010) · Biological Psychiatry

Schizophrenia research and treatmentGenetic Associations and Epidemiology

Cited by 130

Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia

McClay, J. L., Adkins, D. E., Åberg, K., Bukszár, J., Khachane, A. N., Keefe, R. S. E., Perkins, D. O., McEvoy, J. P., Stroup, T. S., Vann, R. E., et al. (2011) · Neuropsychopharmacology

Schizophrenia research and treatmentGenetic Associations and Epidemiology

Cited by 124

Mechanisms of Working Memory Impairment in Schizophrenia

Van Snellenberg, J. X., Girgis, R. R., Horga, G., van de Giessen, E., Slifstein, M., Ojeil, N., Weinstein, J. J., Moore, H., Lieberman, J. A., Shohamy, D., et al. (2016) · Biological Psychiatry

Schizophrenia research and treatmentNeural and Behavioral Psychology Studies

Cited by 123

Understanding the Mechanism of Action of Atypical Antipsychotic Drugs: A Review of Compounds in Use and Development

Lieberman, J. A. (1993) · British Journal of Psychiatry

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 108

Double-Blind Maintenance Safety and Effectiveness Findings From the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) Study

Findling, R. L., Johnson, J. L., McClellan, J., Frazier, J. A., Vitiello, B., Hamer, R. M., Lieberman, J. A., Ritz, L., McNamara, N. K., Lingler, J., et al. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry

Schizophrenia research and treatmentBipolar Disorder and Treatment

Cited by 101

Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial

Javitt, D. C., Carter, C. S., Krystal, J. H., Kantrowitz, J. T., Girgis, R. R., Kegeles, L. S., Ragland, J. D., Maddock, R. J., Lesh, T. A., Tanase, C., et al. (2018) · JAMA Psychiatry

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 100

Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder

Kantrowitz, J. T., Dong, Z., Milak, M. S., Rashid, R., Kegeles, L. S., Javitt, D. C., Lieberman, J. A., & John Mann, J. (2021) · Translational Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 100

Prenatal and Neonatal Brain Structure and White Matter Maturation in Children at High Risk for Schizophrenia

Gilmore, J. H., Kang, C., Evans, D. D., Wolfe, H. M., Smith, J. K., Lieberman, J. A., Lin, W., Hamer, R. M., Styner, M., & Gerig, G. (2010) · American Journal of Psychiatry

Schizophrenia research and treatmentFetal and Pediatric Neurological Disorders

Cited by 97

Double-Blind, Placebo-Controlled Investigation of Amantadine for Weight Loss in Subjects Who Gained Weight With Olanzapine

Graham, K. A., Gu, H., Lieberman, J. A., Harp, J. B., & Perkins, D. O. (2005) · American Journal of Psychiatry

Schizophrenia research and treatmentPharmacology and Obesity Treatment

Cited by 92

Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS): Rationale, Design, and Methods

McCLELLAN, J., SIKICH, L., FINDLING, R. L., FRAZIER, J. A., VITIELLO, B., HLASTALA, S. A., WILLIAMS, E., AMBLER, D., HUNT-HARRISON, T., MALONEY, A. E., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry

Schizophrenia research and treatmentBipolar Disorder and Treatment

Cited by 90

Impairments in Perceptual Competency and Maintenance on a Visual Delayed Match-to-Sample Test in First-Episode Schizophrenia

Lencz, T., Bilder, R. M., Turkel, E., Goldman, R. S., Robinson, D., Kane, J. M., & Lieberman, J. A. (2003) · Archives of General Psychiatry

Schizophrenia research and treatmentCognitive Abilities and Testing

Cited by 89

Advancing drug discovery for schizophrenia

Marder, S. R., Roth, B., Sullivan, P. F., Scolnick, E. M., Nestler, E. J., Geyer, M. A., Welnberger, D. R., Karayiorgou, M., Guidotti, A., Gingrich, J., et al. (2011) · Annals of the New York Academy of Sciences

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Cited by 25

Replicated association of the NR4A3 gene with smoking behaviour in schizophrenia and in bipolar disorder

Novak, G., Zai, C. C., Mirkhani, M., Shaikh, S., Vincent, J. B., Meltzer, H., Lieberman, J. A., Strauss, J., Lévesque, D., Kennedy, J. L., et al. (2010) · Genes, Brain and Behavior

Smoking Behavior and CessationSchizophrenia research and treatment

Cited by 23